Potassium Iodide in Nuclear Accidents: Give it Timely, Swiftly and Judiciously

Endocr Metab Immune Disord Drug Targets. 2023;23(6):873-875. doi: 10.2174/1871530323666221014150729.

Authors

Ioannis Ilias¹, Manfredi Rizzo², Georgios Meristoudis³

Affiliations

¹ Department of Endocrinology, Diabetes and Metabolism, Elena Venizelou Hospital, GR-11521 Athens, Greece.
² Department of Health Promotion Sciences, Maternal and Infantile Care, Internal Medicine and Medical Specialties (Promise), School of Medicine, University of Palermo, Via del Vespro, 141, 90127 Palermo, Italy.
³ Department of Nuclear Medicine, Ippokration Hospital, Thessaloniki, GR-54642, Greece.

PMID: 36239732
DOI: 10.2174/1871530323666221014150729

No abstract available

Keywords: Radiation exposure; environmental exposure; nuclear accidents; potassium iodide; radionuclides; thyroid neoplasms.

MeSH terms

Humans
Potassium Iodide
Radioactive Hazard Release*
Thyroid Neoplasms*

Substances

Potassium Iodide